This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hadron therapy Market

Market Insights on Hadron therapy covering sales outlook, demand forecast & up-to-date key trends

Hadron Therapy Market by Type, Application, End User & Region - Forecast 2022-2032

Hadron Therapy Market Snapshot (2022-2032)

[299 Pages Report] The global hadron therapy market is expected to value US$ 1,412.9 Million in 2022 and reach US$ 4,812 Million by 2032. From 2022-2032, the market is estimated at a CAGR of 11.8%, which was 17.1% for the duration from 2016-21.

The increasing number of cancer cases across the globe is projected to be the key cause driving the global hadron therapy market during the forecast period.

Report Attributes

Details

Projected Market Value (2022)

US$ 1,412.9 Million

Anticipated Forecast Value (2032)

US$ 4,812 Million

Estimated Growth Rate (2022-2032)

11.8%

As per WHO, Cancer is the leading cause of death worldwide, accounting for about 10 million deaths in 2020. And, according to International Agency for Research on Cancer (IARC), by 2040, the global burden of cancers is anticipated to grow to 27.5 million new cancer cases with 16.3 million deaths across the globe.

Proton therapy is anticipated to grow across the globe owing to the rising awareness of its benefits and technological development in the therapy. The introduction of proton therapy in developing countries is expected to provide a lucrative opportunity to the market during the forecast period.

The McLaren Proton Therapy Center is set to become the first in the world to offer proton therapy to patients with Leo Cancer Care’s ground-breaking upright treatment technology. As per the agreement, Leo Cancer Care will install two upright units at the McLaren Proton Therapy Center in Flint, Michigan, with the first patients set to receive care through the innovative treatment delivery system with the FDA’s clearance for the technology.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Factors Driving the Global Hadron Therapy Market?

The increasing number of healthcare facilities offering proton therapy is anticipated to assist the market expansion during the forecast period. Benefits offered by the therapy such as non-invasive treatment, painless procedures, more energy focused on tumors, and less radiation affecting healthy tissue, are likely to drive the market growth during the forecast period.

As per National Cancer Institute (NCI), after 3 years, 46% of patients in the proton therapy group were cancer free and 56% of people who received proton therapy were still alive after 3 years. In addition, an increasing number of healthcare facilities offering proton therapy is projected to help in market growth. For instance, in February 2020, Illinois Health Facilities and Services Review Board approved the OSF HealthCare plan to construct a cancer care center that offers proton-beam therapy. Attributed to such factors, the market for hadron therapy is anticipated to grow significantly during the forecast period.

What are the Factors Hampering the Global Hadron Therapy Market?

Higher costs associated with hadron therapy are anticipated to hinder the global hadron market during the forecast period. The hadron therapy devices are large in size, which is another factor that can limit the market growth. The setup cost is exclusive of the device cost, which further enhances investment. Thus, the industry is projected to suffer during the assessment period.

However, increasing R&D on cancer is anticipated to counter the hampering factors and drive market growth during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Expected to Lead the Global Hadron Therapy Market?

According to the analysis, North America is projected to dominate the global hadron therapy market during the forecast period. As of 2022, the region is likely to secure 42.8% of the global market share. Domination of the region can be attributed to the increasing number of cancer cases across the region.

As per the American Cancer Society, in 2022, there would be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the USA. Increasing initiatives by healthcare facilities in the region are likely to drive the global hadron therapy market. For instance, in 2019, The University of Texas MD Anderson Cancer Center unveiled its plan to expand its Proton Therapy Center. The expansion will be more than double the center’s size to more than 160,000 square feet. An investment of US$ 159 million was announced.

What is the Contribution of Europe to Developing the Global Hadron Therapy Market?

As per the analysis, Europe is anticipated to be the second-largest market for the hadron therapy market. In 2022, the region is likely to secure 38.1% of the total global market share. The presence of high-growth countries such as Germany, the U.K, France, Italy, and Spain is expected to play a significant role in driving the global hadron therapy market during the forecast period.

In May 2020, Hitachi announced that it has provided its advanced proton therapy system to Clinica Universidad de Navarra (Madrid, Spain). Clinica Universidad de Navarra is the first hospital in which Hitachi has delivered the whole proton therapy system in Europe. Attributed to such factors, the market in Europe is projected to witness expansion during the forecast period.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Why is APAC Predicted to be the Most Lucrative Market for Hadron Therapy Market?

As per the analysis, APAC has been identified as the most lucrative market for the Hadron therapy market. This can be attributed to the presence of developing countries like India, China, and Japan.

Increasing awareness about cancer is projected to benefit the market during the forecast period. And, growing initiatives to install proton beam therapy machine in the region is anticipated to benefit the APAC market. For instance, the proton beam therapy machine, which offers sub-millimeter precision in destroying cancer cells, will be installed at the Tata Memorial Center’s (TMC) ACTREC Kharghar center. Attributed to such factors, the market in APAC is likely to flourish during the forecast period.

What is the Contribution of Startups in Developing the Global Hadron Therapy Market?

Insightec, ViewRay, RefleXion, Alpha Tau Medical, Novocure, Profound Medical, HistoSonics, IceCure Medical, B dot, Terapet, and Mevion Medical Systems are some of the emerging entities in the global hadron therapy market.

Growing funding to startups is expected to benefit the market in the assessment period. For instance, Proton therapy developer Mevion Medical Systems announced that it raised US$ 200 million in new equity funding led by Chinese investment firms HOPU Investments and YuangMing Capital. Such support to startups is anticipated to benefit the market in the forecast period.

Competition Analysis

Key players in the global hadron therapy market include Koninklijke Philips N.V., IBA Worldwide, Advanced Oncotherapy, Varian Medical Systems, Inc., Optivus Proton Therapy, Inc., Hitachi, Ltd., Sumitomo Corporation, Mevion Medical Systems, ProNova Solutions, LLC, ProTom International Mitsubishi Electric Corporation, and Elekta.

Major Industry Developments Include:

  • In April 2021, Siemens Healthineers completes the acquisition of Varian Medical Systems, Inc. The acquisition was announced on August 2, 2020. With Varian, Siemens Healthineers has the most comprehensive portfolio in the MedTech sector, which provides the company with considerable potential for value creation. The combined company is offering a unique, highly integrated portfolio of imaging, AI, laboratory diagnostics, and treatment for the global fight against cancer with significant potential for increased value creation.
  • In February 2022, Hitachi, announced that “Shonan Kamakura Advanced Medical Center” at Shonan Kamakura General Hospital of Tokushukai Medical Group, where Hitachi’s compact proton therapy system has been installed, started treatment with the system on 31 January 2022. This is the first order for Hitachi’s dedicated compact proton therapy system.

Report Scope

Report Attribute

Details

Growth Rate (2022-2032)

11.8%

Market Value in 2022

US$ 1,412.9 Million

Market Value in 2032

US$ 4,812 Million

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

USD Million for Value

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Type
  • Application
  • End-User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordic Countries
  • Belgium
  • Netherlands
  • Luxembourg
  • Poland
  • Russia
  • China
  • India
  • ASEAN
  • Australia
  • New Zealand
  • GCC
  • North Africa
  • South Africa

Key Companies Profiled

  • Koninklijke Philips N.V.
  • IBA Worldwide
  • Advanced Oncotherapy
  • Varian Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • Hitachi, Ltd.
  • Sumitomo Corporation
  • Mevion Medical Systems
  • ProNova Solutions, LLC
  • ProTom International Mitsubishi Electric Corporation
  • Elekta

Customization Scope

Available upon Request

Key Segments Profiled in the Global Hadron Therapy Market

Global Hadron Therapy Market by Type:

  • Electron Beam Hadron Therapy
  • Proton Beam Hadron Therapy
  • Neutron Beam Hadron Therapy
  • Carbon Ion Beam Hadron Therapy
  • Alpha Particle Beam Hadron Therapy
  • Beta Particle Beam Hadron Therapy

Global Hadron Therapy Market by Application:

  • Hadron Therapy for Pediatric Cancer
  • Hadron Therapy for Bone & Soft Tissue Cancer
  • Hadron Therapy for Prostate Cancer
  • Hadron Therapy for Lung Cancer
  • Hadron Therapy for Liver Cancer
  • Hadron Therapy for Eye Cancer
  • Hadron Therapy for Head & Neck Cancer

Global Hadron Therapy Market by End User:

  • Hadron Therapy in Hospitals
  • Hadron Therapy in Government Universities
  • Hadron Therapy in Research Institutions

Global Hadron Therapy Market by Region:

  • North American Hadron Therapy Market
  • Latin American Hadron Therapy Market
  • Western European Hadron Therapy Market
  • Eastern European Hadron Therapy Market
  • APAC Hadron Therapy Market
  • Japanese Hadron Therapy Market
  • MEA Hadron Therapy Market

Frequently Asked Questions

The global hadron therapy market is expected to secure a market value US$ 4,812 Million during the forecast period.

The global hadron therapy market is anticipated to exhibit a CAGR of 11.8% during the forecast period.

Koninklijke Philips N.V., IBA Worldwide, and Advanced Oncotherapy are some of the eminent players in the global hadron therapy market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Hadron therapy Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Type Of Particle Radiation

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Type Of Particle Radiation, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type Of Particle Radiation, 2022-2032

        5.3.1. Electron Beam

        5.3.2. Proton Beam

        5.3.3. Neutron Beam

        5.3.4. Carbon Ion Beam

        5.3.5. Alpha Particle Beam

        5.3.6. Beta Particle Beam

    5.4. Y-o-Y Growth Trend Analysis By Type Of Particle Radiation, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Type Of Particle Radiation, 2022-2032

6. Global Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Pediatric Cancer

        6.3.2. Bone & Soft Tissue Cancer

        6.3.3. Prostate Cancer

        6.3.4. Lung Cancer

        6.3.5. Liver Cancer

        6.3.6. Eye Cancer

        6.3.7. Head & Neck Cancer

    6.4. Y-o-Y Growth Trend Analysis By Application, 2016-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

7. Global Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2016-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Government Universities

        7.3.3. Research Institutions

    7.4. Y-o-Y Growth Trend Analysis By End User, 2016-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Type Of Particle Radiation

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type Of Particle Radiation

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Type Of Particle Radiation

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type Of Particle Radiation

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Type Of Particle Radiation

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type Of Particle Radiation

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Type Of Particle Radiation

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type Of Particle Radiation

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. MEA Hadron therapy Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Type Of Particle Radiation

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type Of Particle Radiation

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. Key Countries Hadron therapy Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Type Of Particle Radiation

            14.1.2.2. By Application

            14.1.2.3. By End User

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Type Of Particle Radiation

            14.2.2.2. By Application

            14.2.2.3. By End User

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Type Of Particle Radiation

            14.3.2.2. By Application

            14.3.2.3. By End User

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Type Of Particle Radiation

            14.4.2.2. By Application

            14.4.2.3. By End User

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Type Of Particle Radiation

            14.5.2.2. By Application

            14.5.2.3. By End User

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Type Of Particle Radiation

            14.6.2.2. By Application

            14.6.2.3. By End User

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Type Of Particle Radiation

            14.7.2.2. By Application

            14.7.2.3. By End User

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Type Of Particle Radiation

            14.8.2.2. By Application

            14.8.2.3. By End User

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Type Of Particle Radiation

            14.9.2.2. By Application

            14.9.2.3. By End User

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Type Of Particle Radiation

            14.10.2.2. By Application

            14.10.2.3. By End User

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Type Of Particle Radiation

            14.11.2.2. By Application

            14.11.2.3. By End User

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Type Of Particle Radiation

            14.12.2.2. By Application

            14.12.2.3. By End User

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Type Of Particle Radiation

            14.13.2.2. By Application

            14.13.2.3. By End User

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Type Of Particle Radiation

            14.14.2.2. By Application

            14.14.2.3. By End User

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Type Of Particle Radiation

            14.15.2.2. By Application

            14.15.2.3. By End User

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Type Of Particle Radiation

            14.16.2.2. By Application

            14.16.2.3. By End User

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Type Of Particle Radiation

            14.17.2.2. By Application

            14.17.2.3. By End User

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Type Of Particle Radiation

            14.18.2.2. By Application

            14.18.2.3. By End User

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Type Of Particle Radiation

            14.19.2.2. By Application

            14.19.2.3. By End User

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Type Of Particle Radiation

        15.3.3. By Application

        15.3.4. By End User

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. IBA Worldwide

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Koninklijke Philips N.V.

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Advanced Oncotherapy

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Optivus Proton Therapy, Inc.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Varian Medical Systems, Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Hitachi, Ltd.

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Mevion Medical Systems

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Sumitomo Corporation

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. ProNova Solutions, LLC.

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Mitsubishi Electric Corporation

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Hadron therapy Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 3: Global Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 4: Global Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 5: North America Hadron therapy Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 6: North America Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 7: North America Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 8: North America Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 9: Latin America Hadron therapy Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 10: Latin America Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 11: Latin America Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 12: Latin America Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 13: Europe Hadron therapy Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: Europe Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 15: Europe Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 16: Europe Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 17: Asia Pacific Hadron therapy Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 18: Asia Pacific Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 19: Asia Pacific Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 20: Asia Pacific Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Table 21: MEA Hadron therapy Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 22: MEA Hadron therapy Market Value (US$ Mn) Forecast by Type Of Particle Radiation, 2016-2032

Table 23: MEA Hadron therapy Market Value (US$ Mn) Forecast by Application, 2016-2032

Table 24: MEA Hadron therapy Market Value (US$ Mn) Forecast by End User, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 2: Global Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 3: Global Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Hadron therapy Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Hadron therapy Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 6: Global Hadron therapy Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Hadron therapy Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 9: Global Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 10: Global Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 11: Global Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 12: Global Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 13: Global Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 14: Global Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 15: Global Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 18: Global Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 19: Global Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 20: Global Hadron therapy Market Attractiveness by Region, 2022-2032

Figure 21: North America Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 22: North America Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 23: North America Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 24: North America Hadron therapy Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Hadron therapy Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 26: North America Hadron therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Hadron therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 29: North America Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 30: North America Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 31: North America Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 32: North America Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 33: North America Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 34: North America Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 35: North America Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 38: North America Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 39: North America Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 40: North America Hadron therapy Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 42: Latin America Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 43: Latin America Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 44: Latin America Hadron therapy Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Hadron therapy Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 46: Latin America Hadron therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Hadron therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 49: Latin America Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 50: Latin America Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 51: Latin America Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 52: Latin America Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 53: Latin America Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 54: Latin America Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 55: Latin America Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 58: Latin America Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 59: Latin America Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Hadron therapy Market Attractiveness by Country, 2022-2032

Figure 61: Europe Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 62: Europe Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 63: Europe Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Europe Hadron therapy Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Hadron therapy Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 66: Europe Hadron therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Hadron therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 69: Europe Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 70: Europe Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 71: Europe Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 72: Europe Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 73: Europe Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 74: Europe Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 75: Europe Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 78: Europe Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 79: Europe Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 80: Europe Hadron therapy Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 82: Asia Pacific Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 83: Asia Pacific Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 84: Asia Pacific Hadron therapy Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Hadron therapy Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 86: Asia Pacific Hadron therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Hadron therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 89: Asia Pacific Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 90: Asia Pacific Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 91: Asia Pacific Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 92: Asia Pacific Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 93: Asia Pacific Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 94: Asia Pacific Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 95: Asia Pacific Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: Asia Pacific Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: Asia Pacific Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 98: Asia Pacific Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 99: Asia Pacific Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 100: Asia Pacific Hadron therapy Market Attractiveness by Country, 2022-2032

Figure 101: MEA Hadron therapy Market Value (US$ Mn) by Type Of Particle Radiation, 2022-2032

Figure 102: MEA Hadron therapy Market Value (US$ Mn) by Application, 2022-2032

Figure 103: MEA Hadron therapy Market Value (US$ Mn) by End User, 2022-2032

Figure 104: MEA Hadron therapy Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Hadron therapy Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 106: MEA Hadron therapy Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Hadron therapy Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Hadron therapy Market Value (US$ Mn) Analysis by Type Of Particle Radiation, 2016-2032

Figure 109: MEA Hadron therapy Market Value Share (%) and BPS Analysis by Type Of Particle Radiation, 2022-2032

Figure 110: MEA Hadron therapy Market Y-o-Y Growth (%) Projections by Type Of Particle Radiation, 2022-2032

Figure 111: MEA Hadron therapy Market Value (US$ Mn) Analysis by Application, 2016-2032

Figure 112: MEA Hadron therapy Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 113: MEA Hadron therapy Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 114: MEA Hadron therapy Market Value (US$ Mn) Analysis by End User, 2016-2032

Figure 115: MEA Hadron therapy Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: MEA Hadron therapy Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: MEA Hadron therapy Market Attractiveness by Type Of Particle Radiation, 2022-2032

Figure 118: MEA Hadron therapy Market Attractiveness by Application, 2022-2032

Figure 119: MEA Hadron therapy Market Attractiveness by End User, 2022-2032

Figure 120: MEA Hadron therapy Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cell Therapy Systems Market

Published : September 2017

Healthcare

Phototherapy Treatment Market

Published : January 2022

Healthcare

Negative Pressure Wound Therapy Market

Published : February 2022

Healthcare

Compression Therapy Market

Published : August 2020

Google translate

Hadron therapy Market